Abstract

Cervical malignancy afflicts women of all societies. In Kenya, 4,802 women are diagnosed with cervical malignancy and almost 2500 die annually with only 3.2% of cervical screening uptake. The Main goal of this study was to find out the factors that contribute to the uptake of cervical screening at Mama Lucy Kibaki Hospital. This was a descriptive and cross-sectional study that used a purposeful sampling method. An interview-administered questionnaire was used to collect data from women and hospital key informants. Multivariate regression was used to analyse associations between study variables. A total of 246 participants were recruited. Uptake of cervical screening was 23.1%, with 83.6% being aware of cervical cancer. Fear of results (69.5%), lack of information (69.8%) and fear of the screening procedure (65.2%) were major cervical screening barriers. Free cervical screening (93.5%) comprehensive cancer health education (90.2%), voluntary cervical screening centres (84.9%), mass media cervical cancer campaigns (83.3%) and cervical cancer screening mobile clinics (81.7%) to be the likely motivators to cervical screening uptake. Multivariate regression showed that older women participated more in uptake than young women (p = 0.001), those who had used contraceptives (p=0.001) and those with higher income (p = 0.03). In conclusion, there was a low uptake of screening for cervical cancer disease. A comprehensive and appropriate sensitization program is required, which eventually may increase uptake of cervical screening.

Highlights

  • Cervical malignancy has been found to be the 2nd commonest women cancer universally [1]

  • In 2013, Over 500,000 new cases of cervical malignancy were reported with mortality of over 270,000 [2]

  • Over 5000 females are found to be suffering from cervical cancer

Read more

Summary

Introduction

Cervical malignancy has been found to be the 2nd commonest women cancer universally [1]. Studies from industrialized states have shown that organized programs for cervical screening enable majority of the women to undertake Pap smear test. This has made it possible for most pre-cancer cells to be recognized early. Cervical malignancy mortality rate globally (52%) can be decreased through organized reproductive pelvic examination alongside with treatment program that is effective [6]. This may lead to a significant reduction of overall prevalence and deaths from cervical cancer owing to existing structured screening programs [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call